RecruitingNot Applicable

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

Italy25 participantsStarted 2025-12-05

Plain-language summary

The main aim of the present process-outcome study is to evaluate the feasibility and the effects of an EMDR-IGTP-OTS group intervention on a sample of people with cancer, by using a process-outcome study design, with repeated measures.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * cancer diagnosis * PTSD (IES-R \> 32) Exclusion Criteria: * receiving specialized trauma therapy * receiving current psychiatric pharmacological treatment, unless the dosage has been stable for at least 2 months prior to enrollment

What they're measuring

Impact of Event Scale-Revised (IES-R)

Timeframe: Baseline (T1) and Post-intervention (T2, approximately 1 month), Follow-up (T3, approximately 3 month)

Trial details

NCT IDNCT07447089

SponsorUniversità Cattolica di Milano

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10-01

Contact for this trial

Cesare Cavalera

+393409373408 cesarem.cavalera@unicatt.it

View on ClinicalTrials.gov More Thyroid Neoplasms trials